Mice given drugs that boosted their natural endocannabinoids showed fewer opioid withdrawal symptoms, with the 2-AG pathway showing broader effects than anandamide.
Read this if you want to understand how the endocannabinoid system connects to opioid withdrawal.
MAGL inhibitor reduced most withdrawal symptoms; FAAH inhibitor helped only some
What the researchers found
Morphine-dependent mice challenged with naloxone displayed jumping, paw tremors, diarrhea, and weight loss. The researchers tested two strategies to boost endocannabinoids: blocking MAGL (which breaks down 2-AG) and blocking FAAH (which breaks down anandamide).
The MAGL inhibitor JZL184 reduced most withdrawal symptoms in a dose-dependent manner through CB1 receptors. It also reduced spontaneous withdrawal signs, not just those triggered by naloxone.
The FAAH inhibitor PF-3845 reduced jumping and paw tremors through CB1 receptors but did not help with diarrhea or weight loss. This suggested 2-AG and anandamide play different roles in opioid withdrawal.
Why it matters
Opioid withdrawal is a major barrier to quitting. These findings suggested that boosting the body's own cannabinoids, rather than using external cannabis, could reduce withdrawal severity while potentially avoiding the side effects of direct cannabinoid agonists.
The numbers in context
JZL184 dose-dependently reduced most withdrawal symptoms. PF-3845 reduced jumping and paw tremors but not diarrhea or weight loss. Both effects were blocked by CB1 antagonist rimonabant, confirming the mechanism.
How the study worked
Morphine-dependent mice received naloxone to precipitate withdrawal. Researchers tested MAGL inhibitor JZL184 and FAAH inhibitor PF-3845 at multiple doses, using CB1 and CB2 antagonists to confirm receptor mechanisms. An isolated ileum preparation tested gut-level effects.
What this study cannot tell us
Mouse study only. The doses and routes of administration may not translate to humans. Naloxone-precipitated withdrawal is more abrupt than natural withdrawal. Long-term effects of endocannabinoid enzyme inhibition were not assessed.
How to read the evidence
Animal study with clear mechanistic findings. Strong internal design with receptor antagonist controls, but no human data.
When this study was published
Published in 2011. Research on endocannabinoid enzyme inhibitors for addiction has continued to develop.
The bigger picture
This study contributed to a growing body of evidence connecting the endocannabinoid and opioid systems. The approach of boosting natural endocannabinoids rather than administering external cannabinoids represents a more targeted therapeutic strategy.
Questions still open
- Would MAGL inhibitors work in human opioid withdrawal? Could combining FAAH and MAGL inhibitors produce broader symptom relief? What are the long-term safety implications of sustained endocannabinoid elevation?
Common questions
Is this the same as using cannabis for opioid withdrawal?
Why did the two approaches work differently?
Read the original research
Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
The Journal of pharmacology and experimental therapeutics, 339(1), 173-85
Citation
Ramesh, Divya; Ross, Gracious R; Schlosburg, Joel E; Owens, Robert A; Abdullah, Rehab A; Kinsey, Steven G; Long, Jonathan Z; Nomura, Daniel K; Sim-Selley, Laura J; Cravatt, Benjamin F; Akbarali, Hamid I; Lichtman, Aron H. (2011). Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.. The Journal of pharmacology and experimental therapeutics, 339(1), 173-85. https://doi.org/10.1124/jpet.111.181370
Explore the wider topic
- 30 Days Without Weed: What I Learned
- 6 Months Without Weed: What Nobody Tells You
- 90 Days Weed Free: The Real Long-Term Benefits
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- Benefits of Quitting Weed: What Changes After 30, 60, 90 Days
- Quitting Weed and Boredom: The Hardest Part
- The Boredom Problem: Why Nothing Feels Fun After Quitting Weed
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Creativity After Quitting Weed: What Actually Happens
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Finding New Hobbies After Quitting Weed
- The Stoner Identity Crisis: Who Am I Without Weed?
- Leaving Stoner Culture Behind: Rebuilding Your Identity After Weed
- Money Saved Quitting Weed: The Real Numbers
- Your Nervous System After Quitting Weed: Fight or Flight
- One Year Without Weed: Reflections on What Actually Changed
- Quitting Weed and Creativity: Will I Lose My Spark?
- Does Quitting Weed Change Your Face?
- Quitting Weed and Weight Changes: Why Some People Lose and Others Gain
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)
- THC and Antibiotics: Is It Safe to Use Cannabis While on Antibiotics
- THC and Caffeine: The Most Common Drug Combo on Earth
- THC and Diabetes Medication: Blood Sugar Interactions